CS241484B2 - Method of 3- (4- )2-hydroxy-3-isopropyl-aminopropoxy (phenyl)alkane acids production - Google Patents

Method of 3- (4- )2-hydroxy-3-isopropyl-aminopropoxy (phenyl)alkane acids production Download PDF

Info

Publication number
CS241484B2
CS241484B2 CS814047A CS404781A CS241484B2 CS 241484 B2 CS241484 B2 CS 241484B2 CS 814047 A CS814047 A CS 814047A CS 404781 A CS404781 A CS 404781A CS 241484 B2 CS241484 B2 CS 241484B2
Authority
CS
Czechoslovakia
Prior art keywords
phenyl
hydroxy
iii
formulas
compounds
Prior art date
Application number
CS814047A
Other languages
Czech (cs)
English (en)
Other versions
CS404781A2 (en
Inventor
Enar I Carlsson
Bill B R Gustafsson
Bo T Lundgren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of CS404781A2 publication Critical patent/CS404781A2/cs
Publication of CS241484B2 publication Critical patent/CS241484B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
CS814047A 1980-06-02 1981-06-01 Method of 3- (4- )2-hydroxy-3-isopropyl-aminopropoxy (phenyl)alkane acids production CS241484B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8004087A SE8004087L (sv) 1980-06-02 1980-06-02 Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...

Publications (2)

Publication Number Publication Date
CS404781A2 CS404781A2 (en) 1985-06-13
CS241484B2 true CS241484B2 (en) 1986-03-13

Family

ID=20341101

Family Applications (1)

Application Number Title Priority Date Filing Date
CS814047A CS241484B2 (en) 1980-06-02 1981-06-01 Method of 3- (4- )2-hydroxy-3-isopropyl-aminopropoxy (phenyl)alkane acids production

Country Status (25)

Country Link
EP (1) EP0041491B1 (el)
JP (1) JPS5724335A (el)
KR (1) KR850000869B1 (el)
AT (1) ATE11529T1 (el)
AU (1) AU548290B2 (el)
CS (1) CS241484B2 (el)
DD (1) DD159328A5 (el)
DE (1) DE3168595D1 (el)
DK (1) DK154208C (el)
ES (1) ES8300679A1 (el)
FI (1) FI71725C (el)
GR (1) GR74571B (el)
HU (1) HU184860B (el)
IE (1) IE53801B1 (el)
LU (2) LU88317I2 (el)
MY (1) MY8600219A (el)
NL (1) NL930102I2 (el)
NO (1) NO151282C (el)
NZ (1) NZ197237A (el)
PH (1) PH16135A (el)
PL (1) PL135823B1 (el)
PT (1) PT73111B (el)
SE (1) SE8004087L (el)
SU (1) SU1156592A3 (el)
ZA (1) ZA812981B (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
WO1985004168A1 (en) * 1984-03-14 1985-09-26 Bodor Nicholas S SOFT beta-ADRENERGIC BLOCKING AGENTS
US4829086A (en) * 1984-03-14 1989-05-09 Bodor Nicholas S Soft β-adrenergic blocking agents
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
WO1985004580A1 (en) * 1984-04-09 1985-10-24 American Hospital Supply Corporation Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders
EP0279844A4 (en) * 1986-09-02 1990-06-05 Du Pont AFLÖSUNG VON DE dl-METHYL-3-4- (2-HYDROXY-3-ISOPROPYLAMINO) PROPOXY] PHENYLPROPIONAT (DL-ESMOLOL)].
US5274002A (en) * 1987-04-14 1993-12-28 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
CA2015730C (en) * 1989-05-12 1997-10-07 Sadahiko Iguchi Esters of phenylalkanoic acid
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
EP3101303A4 (en) * 2014-01-29 2017-10-11 Sumitomo Bakelite Co.,Ltd. Brake pad and caliper device
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CR20210441A (es) 2019-01-18 2022-03-11 Astrazeneca Ab Inhibidores de la pcsk9 y métodos de uso de los mismos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB673413A (en) * 1950-03-22 1952-06-04 Rhone Poulenc Sa New local anaesthetics which are substituted benzoic esters and processes for making the same
CH512427A (de) * 1967-12-18 1971-09-15 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Phenoxy-2-hydroxy-3-sec. -alkylaminopropanen
GB1285038A (en) 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
SE354851B (el) * 1970-02-18 1973-03-26 Haessle Ab
FR2132570B1 (el) 1971-04-09 1974-08-02 Lipha
PT66890B (fr) * 1976-08-21 1979-01-25 Hexachimie Procede pour la preparation des aryloxy-1 amino-3 propanol-2

Also Published As

Publication number Publication date
LU88348I2 (fr) 1994-09-09
NL930102I1 (nl) 1993-10-01
AU548290B2 (en) 1985-12-05
KR850000869B1 (ko) 1985-06-22
ATE11529T1 (de) 1985-02-15
CS404781A2 (en) 1985-06-13
DE3168595D1 (en) 1985-03-14
DD159328A5 (de) 1983-03-02
EP0041491B1 (en) 1985-01-30
PT73111A (en) 1981-07-01
ES502656A0 (es) 1982-11-01
NL930102I2 (nl) 1994-12-01
HU184860B (en) 1984-10-29
DK154208C (da) 1989-03-20
NZ197237A (en) 1985-01-31
AU7116681A (en) 1982-12-02
NO151282C (no) 1985-03-13
FI71725B (fi) 1986-10-31
NO151282B (no) 1984-12-03
FI811671L (fi) 1981-12-03
DK239581A (da) 1981-12-03
SU1156592A3 (ru) 1985-05-15
KR830006177A (ko) 1983-09-20
EP0041491A1 (en) 1981-12-09
ZA812981B (en) 1982-05-26
PL135823B1 (en) 1985-12-31
IE53801B1 (en) 1989-03-01
JPS5724335A (en) 1982-02-08
MY8600219A (en) 1986-12-31
PL231450A1 (en) 1983-03-28
FI71725C (fi) 1987-02-09
ES8300679A1 (es) 1982-11-01
LU88317I2 (fr) 1994-05-04
JPS639501B2 (el) 1988-02-29
DK154208B (da) 1988-10-24
SE8004087L (sv) 1981-12-03
NO811799L (no) 1981-12-03
PH16135A (en) 1983-07-08
GR74571B (el) 1984-06-29
IE811217L (en) 1981-12-02
PT73111B (en) 1983-05-11

Similar Documents

Publication Publication Date Title
CS241484B2 (en) Method of 3- (4- )2-hydroxy-3-isopropyl-aminopropoxy (phenyl)alkane acids production
JP3043430B2 (ja) ２−アルキルピロリジン類
EP0065542B1 (en) Compounds suitable for treatment or prophylaxis of cardiac disorders
EP0668851B1 (en) A novel arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent
JPH0587504B2 (el)
JPH05148196A (ja) ４−［２−（２−ヒドロキシ−２−フエニル−エチルアミノ）エトキシフエニル酢酸およびその生前駆体、その製造方法、およびそれを含有する調剤学的組成物
KR850000872B1 (ko) 3-페녹시-1-알콕시카르보닐알킬아미노-프로판올-2 유도체의 제조 방법
CH630068A5 (en) Process for the preparation of 4-hydroxyphenylalkanolamine derivatives
US20140350099A1 (en) Method of Treating or Preventing Pain
RU2196130C2 (ru) Производные аминоэтилфеноксиуксусной кислоты и лекарственные средства для успокоения боли и облегчения отхождения камней при мочекаменной болезни
NO144773B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive aminer
KR100576131B1 (ko) 2­메틸프로피온산유도체 및 그 유도체를 함유하는의약조성물
CS239948B2 (en) Processing of substitute n-carboxamidealkylfenoxypropanolamine
EP0053434A1 (en) Compounds and method for treatment or prophylaxis of cardiac disorders
JPH0633247B2 (ja) ３―アミノプロポキシフェニル誘導体およびその製法ならび用途
JPS60500288A (ja) ３−（３−置換アミノ−２−ヒドロキシプロポキシ）−４−置換−１・２・５−チアゾ−ル誘導体のエステル
JPH0521890B2 (el)
JP2553210B2 (ja) アルドースレダクターゼ抑制剤としてのｎ―ナフトイルグリシン
IL43726A (en) 1-phenoxy-3-(p-carbamoylphenoxy)ethylamino-2-propanol derivatives and pharmaceutical compositions containing them
US6518450B2 (en) Guaiacoxypropanolamines with alpha/beta adrenergic blocking activity
EP0937030B1 (en) 3-amino-propoxyphenyl derivatives (i)
US3288835A (en) Substituted-carbamyl)-alk- oxyj-phenyl acetic acid esters
JPS60105652A (ja) Ｎ‐（４‐アセチルアミノフエナシル）アミン誘導体およびこれを含む治療用組成物ならびにこの誘導体の製造方法
JPS59225170A (ja) アミノプロパノ−ル誘導体、その製造法、および該化合物を含有する心臓選択性β−アドレナリン作用遮断剤
JPH0376302B2 (el)